Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
argenx is seeking a Territory Account Manager to cover Frankfurt, Würzburg and the Nuremberg corridor. You will build and execute account plans, identify key centres for diagnosis and treatment, and develop trusted links with healthcare professionals across a central-German territory.
You will collaborate with medical and commercial partners, manage your own territory priorities and contribute to the growth of VYVGART while maintaining high ethical and regulatory standards.
They start with knowing the customer, understanding access barriers and making smart decisions about where to invest your time. If that is how you already work in specialty biopharma sales, argenx offers the chance to apply it across a varied central-German territory.
Meet is working with argenx to appoint a Territory Account Manager across Frankfurt, Würzburg and the Nuremberg corridor.
Build and execute account plans, identify relevant centres for diagnosis and treatment, and develop trusted links with healthcare professionals. You will work closely with medical and commercial partners, manage your own territory priorities and contribute to the growth of VYVGART® while maintaining high ethical and regulatory standards.
Hospital or specialty-care experience is especially relevant; knowledge of rare diseases or neurology is a distinct plus.
At argenx, we build our culture from the collective power of the team and the knowledge that together, we are better. If you are entrepreneurial, curious and committed to make a difference for patients and thrive on creating solutions for rare autoimmune diseases, then argenx is for you.
Next to a competitive salary with extensive benefits, we offer you the chance to grow and be a part of a team driven by purpose, creativity, innovation and science.
argenx is a fast-growing global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Thanks to colleagues based in Europe, the United States and Japan, we translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines.
We are looking for evidence of delivery, not potential alone. Other German territories are also open to candidates whose location preferences differ.